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Abstract
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There is little empirical evidence on the hospital “cash” prices that self-paying patients (e.g., selfpaying uninsured patients) face, and little empirical evidence of how these hospital cash prices
compare to payer-specific negotiated rates. To address this gap in the literature, I use new data
from U.S. hospitals on their reported cash prices and payer-specific negotiated rates for fourteen
“shoppable” hospital services that are subject to mandated disclosure under a new federal rule that
took effect on January 1, 2021. I find that the cash prices reported by hospitals for these services
vary meaningfully across the United States. For example, hospitals with brain MRI cash prices in
the 90th percentile of the distribution of my data have cash prices 7.9 times more expensive than
hospitals in the 10th percentile. I also find that it is common for the reported cash price to be lower
than several payer-specific negotiated rates within a given hospital. For example, for a given
private payer (e.g. Aetna, Cigna), the share of reported payer-specific negotiated rates that are
higher than the cash price within the same hospital ranges from 41.0 to 57.3 percent. These findings
raise further questions about how hospitals decide to price services for the self-pay uninsured
population and how these cash pricing decisions compare to transaction rates they negotiate with
other payers.
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1. Introduction

Prices play an important role in explaining the sizable differences in healthcare spending between
the United States (U.S.) and other countries (Anderson et al., 2003; Anderson et al., 2019). Recent
work studying hospital prices in the United States uses health insurance claims data recording the
actual negotiated rates between hospitals and private insurance companies to understand the
variation in hospital prices faced by the privately insured (Cooper et al., 2019; Craig et al. 2021).
However, the self-pay cash price (henceforth, “cash price”) for hospital services—for example,
those applicable to self-paying patients who are uninsured—are not captured in these claims data
and remain largely unexplored by economists because of data availability.
To address this gap in the literature, I use new data from U.S. hospitals on their reported cash
prices and payer-specific negotiated rates for fourteen “shoppable” hospital services that are
subject to mandated disclosure under a new federal rule that took effect on January 1, 2021. I use
these data to document the variation in hospital cash prices across the United States for fourteen
hospital services. I find that the cash prices reported by hospitals for these services vary
meaningfully across the United States. For example, hospitals with brain MRI cash prices in the
90th percentile of the distribution of my data have cash prices 7.9 times more expensive than
hospitals in the 10th percentile. I also map the average cash price for a brain MRI and for an
abdominal ultrasound in each Hospital Referral Region (HRR) to provide a picture of the variation
in cash prices across HRRs and to further document the extent of this variation across the country.
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Furthermore, I also compare, for the same service within the same hospital, the reported cash price
to the set of reported payer-specific negotiated rates. I find that it is common for the cash price to
be lower than several payer-specific negotiated rates within a given hospital. For example, 41.4
percent of the reported payer-specific negotiated rates for a CT scan of the pelvis with contrast are
higher than the reported cash price within the same hospital. For other hospital services in the data,
this share ranges from 38.9 to 50.0 percent. Moreover, for a given private payer (e.g. Aetna, Cigna),
the share of reported payer-specific negotiated rates that are higher than the cash price within the
same hospital ranges from 41.0 to 57.3 percent. This finding is interesting since it raises the
question of whether this is evidence of poor bargaining by insurers, who are representing privately
insured consumers in transaction price negotiations with hospitals.

Jou

Documenting the variation in cash prices for hospital services in the United States and comparing
them to payer-specific negotiated rates is important for public policy for several reasons. First,
hospital care represents nearly 6% of the U.S. GDP. Second, self-pay uninsured consumers bear
the full cost of hospital services, and the uninsured rate in the United States increased from 10%
in 2016 to 10.9% in 2019 (Tolbert et al. 2020). Moreover, if medical bills are unpaid, the
outstanding amount can be classified as medical debt and sent to debt collectors. In June 2020, an
estimated 17.8% of individuals in the United States had medical debt (Kluender et al. 2021). Third,
even among insured individuals, hospital cash prices may still be relevant for individuals seeking
services that are not covered by their health plan. Finally, empirical analysis of how hospital
pricing behavior affects self-pay uninsured patients and evidence of how cash prices compare to
payer-specific negotiated rates are scarce.
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2. Background on the new federal regulation and Turquoise Health Co. data

A new federal regulation that took effect on January 1, 2021, requires each hospital operating in
the United States to provide a single, comprehensive, machine-readable file containing the
following standard charges for a list of “shoppable” services provided by the hospital (e.g., office
visits, panel tests, CT scans, MRIs, etc.): (1) gross charge, (2) cash price, (3) all payer-specific
negotiated charges, and (4) de-identified minimum and maximum negotiated charges. The
regulation defines “gross charge” as “the charge for an individual item or service that is reflected
on a hospital’s chargemaster, absent any discounts,” the cash price as “the charge that applies to
an individual who pays cash (or cash equivalent) for a hospital item or service,” and the payerspecific negotiated charge as “the charge that a hospital has negotiated with a third party payer for
an item or service.” The regulation also clarifies that the reported cash price “would reflect the
discounted rate published by the hospital, unrelated to any charity care or bill forgiveness that a
hospital may choose or be required to apply to a particular individual’s bill. Thus, the cash price
is a standard charge offered by the hospital to a group of individuals who are self-pay” (Price
Transparency Requirements for Hospitals to Make Standard Charges Public, 2021). Two important
groups who might self-pay are (1) individuals without health insurance and (2) underinsured
individuals (e.g., individuals seeking services that are not covered by their health plan).

rna

The federal rule defines “shoppable” services as those “that can be scheduled by a healthcare
consumer in advance.” The rule stipulates that hospitals must make public their standard charges
for “as many of the 70 [CMS-specified] shoppable services […] that are provided by that hospital,
and as many additional hospital-selected shoppable services as are necessary for a combined total
of at least 300 shoppable services.” The 70 CMS-specified shoppable services, which are listed in
Table 3 of the final rule, were finalized through the notice and comment rulemaking process and
are based on an analysis of state price transparency requirements, an analysis of high-volume
services and high-cost procedures using claims data and a review by CMS medical officers (Price
Transparency Requirements for Hospitals to Make Standard Charges Public, 2021).
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This paper uses a dataset made available for researchers by Turquoise Health Co., a startup
dedicated exclusively to scraping all U.S. hospital websites to find these machine-readable files,
cleaning the data, and aggregating them. The dataset is publicly available for researchers, and
access instructions are available on the company’s website (https://turquoise.health/researchers).
The Turquoise Health dataset contains the facility fee portion for a curated list of fourteen
shoppable services mandated for disclosure by the Centers for Medicare & Medicaid Services
(CMS). Eleven of the fourteen services are part of the 70 CMS-specified shoppable services of the
final rule. The other three services are: Emergency Department Visits Level 3 (CPT Code 99283),
Level 4 (CPT Code 99284), and Level 5 (CPT Code 99285). Although not considered shoppable,
the three levels of emergency services were included in the Turquoise Health data because
emergency visits are a very common, high-volume hospital service.
The dataset does not include the professional fees associated with the hospital service provided.
Professional fees are fees related to services of employed physicians and non-physician
practitioners, while facility fees refer to items and services provided by a hospital to a patient in
connection with an inpatient admission or an outpatient department visit (e.g. supplies, room and
2
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board, procedures, use of the facility, and other items). Usually, professional fees are billed
separately from the facility fee portion. The raw dataset contains 449,831 observations
representing 2,183 different hospitals, where each observation is a hospital-health plan-serviceprice.
The dataset includes the hospital name and the health system it belongs to; the hospital location,
including street address, city, zip code, county, and state; a description of each shoppable service,
including the relevant numeric code (e.g., CPT, MS-DRG, etc.); a description of the payer-specific
plan associated with each price (e.g., Aetna PPO, Cigna HMO, list price, cash price); and the
corresponding payer-specific negotiated rate applicable to that payer. The geographic information
allows me to uniquely identify a hospital provider and the Hospital Referral Region (HRR) that it
belongs to, and the payer and plan information allow me to compare payer-specific negotiated
rates to cash prices within the same hospital provider.
It is important to also mention some limitations of the Turquoise Health dataset. Not all hospitals
report a self-pay cash price for all services, and hospitals may not necessarily report all payerspecific negotiated rates for all services as stipulated in the new federal rule. Since hospitals do
not uniformly comply with the new federal rule, Turquoise Health Co. warns researchers that the
dataset is provided “as is” and therefore all the analysis in this paper should be interpreted in light
of what hospitals are reporting on their websites via machine-readable files. While being
transparent about the data limitations, Turquoise Health Co. nevertheless has a strong incentive in
finding, collecting, and cleaning these data. The fact that hospitals are not uniformly complying
with the new federal rule has been documented previously (Gondi et al. 2021). However, despite
these limitations, these data offer a unique opportunity to study cash prices and to compare, for the
same service within the same hospital, the cash price to payer-specific negotiated rates (when the
hospital reports both).
3. Hospital cash prices for the same service vary meaningfully across the U.S.

Jou
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In this section, I document the variation in self-pay cash prices across the United States using the
cash prices reported by hospitals complying with the new federal rule. Table 1 reports summary
statistics for the fourteen hospital services contained in the Turquoise Health dataset. I find that
hospital cash prices reported by hospitals under the new rule vary significantly across the United
States. For example, the cash price for an MRI scan of the brain before and after contrast (CPT
70553) at hospitals in the 90th percentile of the cash price distribution is 7.90 times higher than
that at hospitals in the 10th percentile. This ratio is 5.74 for a new patient office visit or other
outpatient 30-minute visit (CPT 99203) and 7.43 for a new patient office visit or other outpatient
45-minute visit (CPT 99205).
Of course, some of this variation may be reflecting unobserved patient severity or unobserved
quality across hospitals. However, meaningful cash price variation is also present for plausibly
homogenous services like a kidney function blood test panel (CPT 80069), an ultrasound of the
abdomen (CPT 76700), and a routine electrocardiogram with interpretation and report (CPT
93000). Taken together, these descriptive results suggest that cash prices for hospital services
reported by hospitals under the new federal rule vary meaningfully across the United States.
3
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Table 1
Summary Statistics for the Reported Self-Pay Cash Prices across the 14 Services Contained in the Dataset
Service Description
Code Type Code
Service Category
Number of Providers
MRI scan of brain before and after contrast
CPT
70553
MRI
1,731
Colonoscopy, diagnostic
CPT
45378
Digestive
1,034
CT scan, pelvis, with contrast
CPT
72193
CT scan
1,657
Electrocardiogram, routine, with interpretation and report
CPT
93000
Cardiovascular
398
Emergency, Level 3
CPT
99283
Emergency care
1,475
Emergency, Level 4
CPT
99284
Emergency care
1,469
Emergency, Level 5
CPT
99285
Emergency care
1,469
Kidney function blood test panel
CPT
80069 Organ or disease oriented panels
1,647
Knee arthroscopic cartilage removal
CPT
29881
Musculoskeletal
678
New patient office or other outpatient visit, typically 30 minutes
CPT
99203
Office visit
1,084
New patient office or other outpatient visit, typically 45 minutes
CPT
99204
Office visit
1,081
New patient office or other outpatient visit, typically 60 minutes
CPT
99205
Office visit
998
Ultrasound of abdomen, complete
CPT
76700
Ultrasound
1,728
Uterine and adnexa procedures, non-malignancy
MSDRG 743
Female reproductive
707
Source: Turqoise Health Limited Research Dataset

Mean Std. Dev. min
3,169
2,518
328
2,553
3,233
89
1,913
1,770
174
116
93
5
815
694
74
1,232
977
119
1,759
1,488
165
165
256
9
7,667
6,389
565
240
202
26
313
279
28
386
361
28
832
755
105
25,419 17,142 3,673

p10
778
579
489
21
221
357
501
22
1,838
80
91
103
196
7,803

p90
6,139
4,994
3,806
208
1,755
2,495
3,575
322
17,320
459
649
761
1,616
49,052

max
14,476
37,451
12,392
446
4,477
7,062
10,704
1,783
30,922
1,345
1,865
2,493
4,817
81,789

p90/p10 ratio
7.90
8.62
7.79
9.90
7.96
7.00
7.14
14.79
9.42
5.74
7.15
7.43
8.25
6.29

4. Average hospital cash prices across Hospital Referral Regions

Figure 1 maps the average reported cash price in each HRR using the available data for a brain
MRI and an abdominal ultrasound. These maps provide descriptive evidence that there is a
meaningful amount of variation in the cash prices applicable to self-pay individuals (e.g., the
uninsured) across HRRs. For example, self-pay patients getting a brain MRI within the HRR in
the 90th percentile of the HRR average cash price distribution (e.g., Cape Girardeau, MO) will pay,
on average, 4.26 times more than self-pay patients getting a brain MRI within the HRR in the 10th
percentile of the HRR average cash price distribution (e.g., Bridgeport, CT).

rna

Figure 1

5. Self-pay cash prices can be lower than payer-specific negotiated rates

Jou

The data reported by hospitals under the new rule also allow me to compare, for the same service,
the reported cash price and the reported payer-specific negotiated rates within the same hospital
when the hospital reports both. Importantly, this comparison allows me to hold hospital quality
constant. Figure 2 graphs and compares these rates for a CT scan of the pelvis (CPT 72193). Each
darkly shaded dot in Figure 2 represents a single hospital’s reported cash price, and hospitals are
ordered by cash price in ascending order. Lightly shaded dots above and below each hospital’s
darkly shaded dot represent the reported negotiated prices for the CT scan within the same hospital.
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Figure 2 qualitatively demonstrates that it is common for the reported cash price to be lower than
several reported payer-specific negotiated rates within the same hospital. This also happens for
other services in the data. For example, Table 2 shows, for a given hospital service, the share of
reported payer-specific negotiated rates that are higher than the reported cash price within the same
hospital. Notice that this share ranges from 38.9 to 50.0 percent across the fourteen services.

rna

Figure 2
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Table 2
Share of reported payer-specific negotiated rates that are higher than the cash price within the same hospital across the 14 services in the data
Number of providers
Number of
Number of payer-specific rates
Service Description
reporting a cash price
payer-specific
that are higher than the cash
and at least one negotiated rate
negotiated rates
price within the same provider
MRI scan of brain before and after contrast
1,385
34,094
13,268
Colonoscopy, diagnostic
891
22,233
10,544
CT scan, pelvis, with contrast
1,325
31,452
13,024
Electrocardiogram, routine, with interpretation and report
331
6,410
3,143
Emergency, Level 3
1,158
37,671
17,425
Emergency, Level 4
1,153
38,660
18,035
Emergency, Level 5
1,155
38,420
17,692
Kidney function blood test panel
1,271
31,778
13,180
Knee arthroscopic cartilage removal
562
13,090
6,467
New patient office or other outpatient visit, typically 30 minutes
786
19,991
9,634
New patient office or other outpatient visit, typically 45 minutes
785
19,613
9,807
New patient office or other outpatient visit, typically 60 minutes
717
18,381
9,080
Ultrasound of abdomen, complete
1,390
35,546
14,539
Uterine and adnexa procedures, non-malignancy
597
14,144
7,051
Source: Turqoise Health Limited Research Dataset

Percent
higher than
cash
38.9%
47.4%
41.4%
49.0%
46.3%
46.7%
46.0%
41.5%
49.4%
48.2%
50.0%
49.4%
40.9%
49.9%

To provide further evidence of this stylized fact, Table 3 shows, for a given insurer, the share of
reported payer-specific negotiated rates that are higher than the reported cash price within the same
hospital. I focus on Aetna, Blue Cross Blue Shield, Cigna, Humana and United Health since they
5
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are major national carriers. I also include a government-related payer category which groups plans
whose payers are listed as Medicaid, Medicare, Tricare, Veterans Affairs, and state agencies
insuring their state employees, among others. In this case, for a given payer (e.g. Humana, Cigna),
the share of reported payer-specific negotiated rates that are higher than the cash price within the
same hospital ranges from 41.0 to 57.3 percent. This range is notably higher than 18.4%, the
percent of reported government rates that are higher than cash within the same hospital and service.
Table 3
Share of reported payer-specific negotiated rates that are higher than the cash price within the same hospital across major payers
Number of providers
Number of
Number of payer-specific rates
Percent
Payer
reporting a cash price
payer-specific
that are higher than the cash
higher than
and at least one negotiated rate negotiated rates price within the same provider
cash
Aetna
1,092
21,104
11,751
55.7%
BCBS (Blue Cross Blue Shield)
1,136
32,905
13,489
41.0%
Cigna
975
14,998
8,601
57.3%
Humana
697
8,293
3,988
48.1%
United Health
970
16,970
8,609
50.7%
Government Plans
1,212
Other
1,410
Source: Turqoise Health Limited Research Dataset

90,926
176,287

16,771
99,680

18.4%
56.5%

Conclusion

rna

This finding is interesting since individuals purchasing private health insurance are paying
monthly premiums in exchange for having access to health care services within a network of
providers under the promise that their insurer is also negotiating the lowest possible rates for
services delivered within that hospital network. On the other hand, the qualitative analysis above
shows that it is common to find cases were the cash prices applicable to the uninsured (who have
no one to negotiate on their behalf and lack the bargaining power of an insurance company) are
lower than some payer-specific rates. This suggests that further research is needed to understand
how hospitals decide to price services for the uninsured population and how these cash pricing
decisions compare to transaction rates they negotiate with other payers. It also raises the question
of whether this is evidence of poor bargaining by insurers, who are representing privately insured
consumers in price negotiations with hospitals.

Jou

Using new data reported by U.S. hospitals on the cash price and payer-specific negotiated rates
applicable to hospital services, I find that the cash prices reported by hospitals vary meaningfully
across the United States. To the best of my knowledge, this is the first paper to document such
variation using a nationally comprehensive dataset that contains self-pay cash prices reported by
hospitals across the United States. I also find that it is common for the cash price to be lower than
several payer-specific negotiated rates within a hospital. Further research should be focused on
understanding the economic forces behind the patterns identified in this paper. Also, more research
is needed in terms of understanding how hospitals decide to price their services to self-paying,
uninsured patients. This paper offers a first attempt at establishing some stylized facts on the set
of cash prices they are reporting under the new federal regulation and how they compare to payerspecific rates.
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I use new data from U.S. hospitals on their reported cash prices and payer-specific
negotiated rates for fourteen “shoppable” hospital services that are subject to mandated
disclosure under a new federal rule that took effect on January 1, 2021.
I find that the cash prices reported by hospitals for these services vary meaningfully
across the United States.
For example, hospitals with brain MRI cash prices in the 90th percentile of the
distribution of my data have cash prices 7.9 times more expensive than hospitals in the
10th percentile.
I also compare, for the same service within the same hospital, the reported cash price to
the set of reported payer-specific negotiated rates. I find that it is common for the cash
price to be lower than several payer-specific negotiated rates within a given hospital.
This finding is interesting since it raises the question of whether this is evidence of poor
bargaining by insurers, who are representing privately insured consumers in transaction
price negotiations with hospitals.
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